loading
전일 마감가:
$123.67
열려 있는:
$124.26
하루 거래량:
8.07M
Relative Volume:
1.18
시가총액:
$216.09B
수익:
$43.11B
순이익/손실:
$13.98B
주가수익비율:
15.56
EPS:
7.98
순현금흐름:
$6.66B
1주 성능:
-5.80%
1개월 성능:
-6.48%
6개월 성능:
+6.49%
1년 성능:
+21.90%
1일 변동 폭
Value
$121.60
$126.03
1주일 범위
Value
$119.77
$133.03
52주 변동 폭
Value
$99.92
$140.84

애보트 래버러토리스 Stock (ABT) Company Profile

Name
명칭
Abbott Laboratories
Name
전화
(224) 667-6100
Name
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
직원
114,000
Name
트위터
@AbbottNews
Name
다음 수익 날짜
2025-07-17
Name
최신 SEC 제출 서류
Name
ABT's Discussions on Twitter

ABT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
ABT
Abbott Laboratories
124.20 229.71B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.94 154.35B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
388.38 149.60B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
89.84 114.97B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.62 45.92B 5.54B 4.18B 623.10M 7.00

애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-18 업그레이드 Jefferies Hold → Buy
2025-06-16 개시 Leerink Partners Market Perform
2024-10-08 개시 Oppenheimer Outperform
2024-09-19 개시 Piper Sandler Overweight
2024-07-30 다운그레이드 Edward Jones Buy → Hold
2024-05-30 개시 Goldman Buy
2023-07-21 업그레이드 Wolfe Research Underperform → Peer Perform
2023-05-30 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-04-20 재확인 Barclays Overweight
2023-04-20 재확인 Bernstein Outperform
2023-04-20 재확인 JP Morgan Overweight
2023-04-20 재확인 Raymond James Outperform
2023-04-20 재확인 UBS Buy
2023-04-20 재확인 Wolfe Research Underperform
2023-03-29 개시 UBS Buy
2022-10-26 개시 Mizuho Neutral
2022-10-18 개시 Barclays Overweight
2022-10-12 개시 Jefferies Hold
2022-07-06 개시 Wolfe Research Underperform
2022-03-02 재개 BofA Securities Buy
2022-01-27 재확인 Credit Suisse Outperform
2022-01-27 재확인 Morgan Stanley Overweight
2022-01-27 재확인 Raymond James Outperform
2022-01-27 재확인 UBS Buy
2021-12-10 개시 RBC Capital Mkts Outperform
2021-10-27 업그레이드 Atlantic Equities Neutral → Overweight
2021-10-14 개시 Redburn Neutral
2021-05-25 개시 Barclays Overweight
2021-04-15 개시 Atlantic Equities Neutral
2021-01-28 업그레이드 BTIG Research Neutral → Buy
2020-09-11 개시 Wolfe Research Outperform
2020-06-01 다운그레이드 Goldman Neutral → Sell
2020-03-05 개시 Citigroup Buy
2020-02-13 개시 Goldman Neutral
2020-02-06 재개 BTIG Research Neutral
2020-01-02 다운그레이드 Guggenheim Buy → Neutral
2019-06-13 재확인 BofA/Merrill Buy
2019-02-07 재확인 BofA/Merrill Buy
2019-01-02 다운그레이드 Citigroup Neutral → Sell
2018-11-30 업그레이드 Goldman Neutral → Buy
2018-10-16 개시 Barclays Overweight
2018-06-27 개시 Bernstein Outperform
2018-01-30 재확인 Citigroup Neutral
2018-01-25 재확인 Stifel Buy
2018-01-25 업그레이드 William Blair Mkt Perform → Outperform
2018-01-03 개시 Evercore ISI Outperform
2018-01-02 업그레이드 JP Morgan Neutral → Overweight
2018-01-02 업그레이드 Morgan Stanley Equal-Weight → Overweight
2017-10-19 재확인 RBC Capital Mkts Outperform
2017-10-19 재확인 Stifel Buy
모두보기

애보트 래버러토리스 주식(ABT)의 최신 뉴스

pulisher
10:23 AM

Abbott Labs stock rating reiterated at Buy by UBS despite guidance cut - Investing.com South Africa

10:23 AM
pulisher
09:00 AM

Abbott Laboratories (ABT): I Am Very Upset With Abbott,” Says Jim Cramer - MSN

09:00 AM
pulisher
Jul 20, 2025

Abbott Laboratories falls after setting Q3 outlook below consensus - MSN

Jul 20, 2025
pulisher
Jul 20, 2025

Abbott Laboratories Stock (ABT) Opinions on Q2 Earnings and Guidance Update - Quiver Quantitative

Jul 20, 2025
pulisher
Jul 20, 2025

Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings Call Transcript - MSN

Jul 20, 2025
pulisher
Jul 20, 2025

Notable healthcare headlines for the week: Trump’s tariff threats, J&J, Abbott Laboratories and Sarepta in focus - MSN

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Abbott Laboratories stockFree Wealth Management Insights - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Abbott Laboratories stock priceHigh-performance investment picks - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Abbott Laboratories (ABT) a Buy After the Earnings Selloff? - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

Abbott Drops After Lowering Top End of Full-Year Guidance - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Abbott Laboratories: A Medtech Titan Positioned for Growth in a Transformed Healthcare Landscape - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

Abbott Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

Jul 19, 2025
pulisher
Jul 19, 2025

Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $135 to $159 - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

How Abbott Laboratories (ABT) Balances Innovation with Shareholder Payouts - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories Stock Analysis and ForecastRobust investment performance - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories Trading Volume Drops 27.57% to $24.28 Billion Ranking 25th - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Netflix, Abbott Labs Lead Friday’s Market Cap Stock Movers By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Netflix, Abbott Labs Lead Friday’s Market Cap Stock Movers - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (NYSE:ABT) Releases Mixed Earnings Report - FXDailyReport.Com

Jul 18, 2025
pulisher
Jul 18, 2025

Analysts defend Abbott Labs' stock after Thursday's 'too punitive' sell-off - CNBC

Jul 18, 2025
pulisher
Jul 18, 2025

Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

Scott+Scott Attorneys at Law LLP Alerts Investors There Is an Ongoing Securities Class Action Against Reckitt Benckiser Group PLC (OTC: RBGLY) - GlobeNewswire Inc.

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (ABT) Drops on Lower Full-Year Guidance - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott upgraded to Buy at Jefferies despite underwhelming outlook - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock price target lowered to $155 at Citi on China diagnostics headwinds - Investing.com UK

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Upgraded by Jefferies as Stock Selloff Seen as Overreaction - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (ABT) Stock: Q2 Beat Masks Challenges from COVID Test Decline, Tariffs, and China Pressure - CoinCentral

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Leaps on Recent Stock Fluctuations - Baystreet.ca

Jul 18, 2025
pulisher
Jul 18, 2025

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year? - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Down 9.0% in 4 Weeks, Here's Why Abbott (ABT) Looks Ripe for a Turnaround - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Buy Rating on Abbott Laboratories: Attractive Valuation Amid Growth Prospects and Market Overreaction - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

These Analysts Revise Their Forecasts On Abbott Following Q2 Results - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock falls 8% as China headwinds prompt guidance cut - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $140 to $153 - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories: What's Behind The Q2 Earnings Slump? (NYSE:ABT) - Seeking Alpha

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock falls 8% as China headwinds prompt guidance cut By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott upgraded after post-earnings selloff, hardware drag seen temporary - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott upgraded after post-earnings selloff, hardware drag seen temporary By Investing.com - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock price target lowered to $135 by Mizuho on guidance cut - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

As new tariffs loom, United shrugs while Abbott braces for a hit - Crain's Chicago Business

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock rating upgraded by Jefferies on growth outlook - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (ABT) Q2 2025 Earnings Call Highlights: Strong Growth in Medical Devices ... - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (ABT) Q2 2025 Earnings Call Highlights: Stro - GuruFocus

Jul 18, 2025
pulisher
Jul 18, 2025

Here's what to expect from Abbott's Q2 earnings - MSN

Jul 18, 2025

애보트 래버러토리스 (ABT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices BSX
$103.47
price down icon 0.23%
medical_devices SYK
$388.77
price down icon 0.16%
medical_devices MDT
$89.66
price up icon 0.04%
medical_devices EW
$77.57
price up icon 0.97%
$75.58
price down icon 0.61%
자본화:     |  볼륨(24시간):